In a filing, PTC Therapeutics Inc revealed its CHIEF TECHNICAL OPS OFFICER Almstead Neil Gregory unloaded Company’s shares for reported $3.62 million on Dec 02 ’24. In the deal valued at $52.06 per share,69,550 shares were sold. As a result of this transaction, Almstead Neil Gregory now holds 86,202 shares worth roughly $4.19 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Almstead Neil Gregory sold 2,060 shares, generating $107,063 in total proceeds. Upon selling the shares at $51.97, the CHIEF TECHNICAL OPS OFFICER now owns 4,576 shares.
Before that, ZELDIS JEROME B sold 24,000 shares. PTC Therapeutics Inc shares valued at $1,235,897 were divested by the Director at a price of $51.50 per share. As a result of the transaction, ZELDIS JEROME B now holds 14,500 shares, worth roughly $0.7 million.
Morgan Stanley upgraded its PTC Therapeutics Inc [PTCT] rating to an Overweight from a an Equal-weight in a research note published on December 13, 2024; the price target was increased to $67 from $45. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in early December from “a Sector perform” to “an Outperform”. Robert W. Baird started covering the stock on September 04, 2024. It rated PTCT as “an Outperform”.
Price Performance Review of PTCT
On Monday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock jump 4.83% to $48.61. Over the last five days, the stock has gained 1.14%. PTC Therapeutics Inc shares have risen nearly 76.38% since the year began. Nevertheless, the stocks have risen 76.12% over the past one year. While a 52-week high of $54.16 was reached on 12/03/24, a 52-week low of $23.58 was recorded on 02/13/24. SMA at 50 days reached $42.79, while 200 days put it at $35.18.
Levels Of Support And Resistance For PTCT Stock
The 24-hour chart illustrates a support level at 46.82, which if violated will result in even more drops to 45.02. On the upside, there is a resistance level at 49.59. A further resistance level may holdings at 50.56. The Relative Strength Index (RSI) on the 14-day chart is 57.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.55%. Stochastics %K at 40.17% indicates the stock is a holding.
How much short interest is there in PTC Therapeutics Inc?
A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2024-11-29, dropping by -0.29 million shares to a total of 4.6 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.89 million shares. There was a decline of -6.31%, which implies that there is a negative sentiment for the stock.
